Preparation and evaluation of the self emulsifying drug delivery system containing Atorvastatin HMG-COA inhibiter

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 3, Issue 3, 2011, Pages 147-152

  Chouksey, Rajendra ^a   Pandey, Harish ^b   Jain, A K ^c   Soni, Himesh ^d   Saraogi, G K ^d  

^a Gyan Bihar University   (India)

^b Sai Satya Sai College of Pharmacy   (India)

^c G R MEDICAL COLLEGE   (India)

^d Lakshmi Narain College of Pharmacy   (India)

Author keywords

Atorvastatin; Bioavailability; Oral drug delivery; Self emulsifying drug delivery systems

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ATORVASTATIN; COSURFACTANT; SURFACTANT;

ARTICLE; DISPERSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMULSION; FREEZE THAWING; PARTICLE SIZE; THERMOSTABILITY; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY;

EID: 79960796807     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gursoy RN, Benita S, Self-emulsifying drug delivery systems (SEDDS) for Improved Oral delivery of lipophilic drugs. Biomedicine and Pharmacotherapy 2004; 58:173-182.
2. Tamilvanan S and Benita S The potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur. J. Pharm. Biopharm., 2004, 58, 357-368.
3. Gursoy N, Garrigue JS, Razafindratsita A, Lambert G and Benita S, Excipient effects on in vitro cytotoxicity of a novel paclitaxel self-emulsifying drug delivery system. J. Pharm. Sci., 2003, 92, 2420-2427.
4. Ichikawa H, Watanabe T, Tokumitsu H, Fukumori Y Formulation considerations of gadolinium lipid nanoemulsion for intravenous delivery to tumors in neutron-capture therapy Curr. Drug Deliv., 2007, 4, 131-40.
5. http://www.microfluidicscorp.com
6. Kumar M, Misra A, Babbar AK, Mishra AK, Mishra P, Pathak K Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int. J. Pharm., 2008, 358, 285-91.
7. Teixeira H, Dubernet C, Rosilio V, Scherman D, Benita S Factors influencing the oligonucleotides release from O/W submicron cationic emulsions. J. Cont. Rel., 2001, 70, 243-55.
8. Dixit N., Kohli K., Baboota S. Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovascular drug. J. Pharm. Sci Tech. 2008, 62, 46-55.
9. Rao SV, Shao J, Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs formulation development, Int. J. Pharm., 2008, 362, 2-9.
10. Mason TG, Nanoemulsions: formation, structure, and physical properties, J. Phys.: Condens. Matter, 2006, 18, R-635.
11. Baboota S., Shakeel F., Ahuja A., Ali J., and Shafiq S. Design development and evaluation of novel nanoemulsions. Pharm., 2007, 8, 316-332.
12. Shafiq F, Shakeel S, Talegaonkar FJ, Khar RK and M Ali Design and development of oral oil in water ramipril nanoemulsion formulation: In vitro and in vivo assessment, J. Biomed. Nanotech, 2007, 3, 28-44.
13. Paolino D, Ventura CA, Nistico S, Puglisi G, and Fresta M Lecithin microemulsions for the topical administration of ketoprofen: percutaneous absorption through human skin and in vivo human skin tolerability, Int. J. Pharm., 2002, 244, 21-31.
14. Shafiq F, Shakeel S, Talegaonkar F, Ahmad J, Khar RK and Ali M Design and development of oral oil in water ramipril nanoemulsion formulation: In vitro and in vivo assessment, J. Biomed. Nanotech., 2007,3, 28-44.
15. Ping Zhang, Ying Liu, Nianping Feng, Jie Xu.Preparation and evaluation of self- microemulsifying drug delivery system of oridonin Int. J. Pharma., 2008, 355, 269-276
16. Pouton CW Formulation of self-emulsifying drug delivery systems. Adv. Drug Delivery Rev., 1997, 25, 27-58
17. Shafiq SF, Shakeel F, Talegaonkar S, Ahmad FJ, Khar R.K,and Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation, Eur. J. Pharm. Biopharm. 2007, 66, 227-242
18. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M and Shafiq S Nanoemulsions as vehicles for transdermal delivery of aceclofenac, AAPS Pharm. Sci. Tech., 2007, 8, E104
19. Baboota S., Alazaki A., Kohli K., Ali J., Dixit N. and Shakeel F. Development and evaluation of a microemulsion formulation for transdermal delivery of terbenafine, PDA J. Pharm. Sci. Tech., 2007, 61, 276-285
20. Paolino D, Ventura CA, Nistico S, Puglisi G, and Fresta M Lecithin microemulsions for the topical administration of ketoprofen: percutaneous absorption through human Skin and in vivo human skin tolerability, Int. J. Pharm.,2002, 244, 21-31
21. Floyd AG Top ten considerations in the development of parenteral emulsions, Pharm. Sci. Tech. Today, 1999, 2, 134-143.
22. Khoo SM, Humberstone AJ, Porter CJH, et al., Formulation design and bioavailability assessment of lipidic self-emulsifying formulation of halofantrine Int J Pharm., 1998, 167, 155-164.
23. Kunieda H, Horii M, Koyama M, et al., Solubilization of polar oils in surfactant self-organized structures J Colloid Interface Sci., 2001, 236, 78-84.